Jill U. Adams is a freelance science journalist based in Albany, New York. She covers health, mental health and biomedical research for such publications as The Transmitter, The Washington Post, Scientific American, Undark and The Scientist. She has a Ph.D. in pharmacology from Emory University in Atlanta, Georgia.
Jill Adams
Contributing writer
From this contributor
Leucovorin, long-read sequencing, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 March.
Portfolio of SCN2A gene variants, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 9 March.
Autism in old age, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 March.
In-vivo base editing in a mouse model of autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 23 February.
In-vivo base editing in a mouse model of autism, and more
By
Jill Adams
24 February 2026 | 2 min read
New insights on sex bias in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 February.
Explore more from The Transmitter
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
Trading places: What happens when neuroscience turns into machine learning, and machine learning turns into neuroscience?
Neuroscience has become increasingly concerned with prediction, and machine learning with causal explanation, with each field adopting methods from the other. I asked eight experts to weigh in on what we stand to learn from this exchange.
By
Samuel Gershman
23 March 2026 | 22 min read
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.
Exon-skipping approach boosts levels of key Rett syndrome protein
Deleting a small region of the MECP2 gene partially restored function in neurons derived from people with Rett-associated variants.
By
Giorgia Guglielmi
20 March 2026 | 5 min read
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
By
Katie Moisse
19 March 2026 | 6 min read